Pharmaceutical

Menarini to enhance BPDCN detection with VisualDx’s link

Menarini Group has announced a partnership with VisualDx to enhance the diagnosis of individuals with BPDCN.

Mar 23, 2025 - 06:00
Menarini to enhance BPDCN detection with VisualDx’s link
Menarini Group has announced a partnership with VisualDx to enhance the diagnosis of individuals with BPDCN.
Read the original article

Tags:

Previous Article

How to manage regulatory complexities with clinical trial data

Next Article

Funding drought: how can biotech and biopharma keep trials running?

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Goldman Sachs launches $650 million fund for life sciences investments

STAT+: Goldman Sachs launches $650 million fund for lif...

Jan 4, 2024

GLP-1 drugs not linked to suicidal thoughts in FDA’s early review

GLP-1 drugs not linked to suicidal thoughts in FDA’s ea...

Jan 12, 2024

The scientist studying how fugitive fetal cells may affect maternal health

The scientist studying how fugitive fetal cells may aff...

Nov 1, 2023